These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 27118493)

  • 1. Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects.
    Shaked Y
    Nat Rev Clin Oncol; 2016 Oct; 13(10):611-26. PubMed ID: 27118493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Yin and Yang' in inflammation: duality in innate immune cell function and tumorigenesis.
    Khatami M
    Expert Opin Biol Ther; 2008 Oct; 8(10):1461-72. PubMed ID: 18774915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can inhibition of angiogenesis and stimulation of immune response be combined into a more effective antitumor therapy?
    Szala S; Mitrus I; Sochanik A
    Cancer Immunol Immunother; 2010 Oct; 59(10):1449-55. PubMed ID: 20552191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The host immunological response to cancer therapy: An emerging concept in tumor biology.
    Voloshin T; Voest EE; Shaked Y
    Exp Cell Res; 2013 Jul; 319(11):1687-95. PubMed ID: 23518388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yin-yang regulating effects of cancer-associated genes, proteins, and cells: An ancient Chinese concept in vogue in modern cancer research.
    Wei S
    Biosci Trends; 2018 Jan; 11(6):612-618. PubMed ID: 29238002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy and immunotherapy: a beneficial liaison?
    Weichselbaum RR; Liang H; Deng L; Fu YX
    Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two Opposing Effects (Yin and Yang) Determine Cancer Progression.
    Huang S; Kurubanjerdjit N; Xu W
    Crit Rev Oncog; 2017; 22(1-2):143-155. PubMed ID: 29604942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological basis of 'Yin-nourishing' and 'Yang-invigorating' actions of Cordyceps, a Chinese tonifying herb.
    Siu KM; Mak DH; Chiu PY; Poon MK; Du Y; Ko KM
    Life Sci; 2004 Dec; 76(4):385-95. PubMed ID: 15530501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination cancer immunotherapy and new immunomodulatory targets.
    Mahoney KM; Rennert PD; Freeman GJ
    Nat Rev Drug Discov; 2015 Aug; 14(8):561-84. PubMed ID: 26228759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is cancer a severe delayed hypersensitivity reaction and histamine a blueprint?
    Khatami M
    Clin Transl Med; 2016 Dec; 5(1):35. PubMed ID: 27558401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Yin-yang relationship between oncogene and antioncogene].
    Jia YS; Zheng JQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jan; 29(1):72-5. PubMed ID: 19338159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms and future directions for angiogenesis-based cancer therapies.
    Scappaticci FA
    J Clin Oncol; 2002 Sep; 20(18):3906-27. PubMed ID: 12228212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumour and immune-adjuvant activities of protein-tyrosine kinase inhibitors.
    Seliger B; Massa C; Rini B; Ko J; Finke J
    Trends Mol Med; 2010 Apr; 16(4):184-92. PubMed ID: 20304705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yin-yang activities and vicious cycles in the tumor microenvironment.
    Witz IP
    Cancer Res; 2008 Jan; 68(1):9-13. PubMed ID: 18172289
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospects for combining targeted and conventional cancer therapy with immunotherapy.
    Gotwals P; Cameron S; Cipolletta D; Cremasco V; Crystal A; Hewes B; Mueller B; Quaratino S; Sabatos-Peyton C; Petruzzelli L; Engelman JA; Dranoff G
    Nat Rev Cancer; 2017 May; 17(5):286-301. PubMed ID: 28338065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic treatments of inflammatory breast cancer: an overview].
    Monneur A; Bertucci F; Viens P; Gonçalves A
    Bull Cancer; 2014 Dec; 101(12):1080-8. PubMed ID: 25475708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yin and yang: the case for integrative cancer care.
    Rodriguez AO
    Curr Opin Obstet Gynecol; 2006 Feb; 18(1):1-2. PubMed ID: 16493251
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic control of tumour progression and antitumour immunity.
    Huang L; Mellor AL
    Curr Opin Oncol; 2014 Jan; 26(1):92-9. PubMed ID: 24305570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard therapies versus novel therapies in Hodgkin lymphoma.
    Gallamini A; Di Raimondo F; La Nasa G; Romano A; Borra A; Greco M
    Immunol Lett; 2013; 155(1-2):56-9. PubMed ID: 24140162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.